Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

Jairo A. Garcia, Lewis R. Roberts

Research output: Contribution to journal › Comment/debate › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma'. Together they form a unique fingerprint.